ILOTYCIN GLUCEPTATE Drug Patent Profile
✉ Email this page to a colleague
When do Ilotycin Gluceptate patents expire, and what generic alternatives are available?
Ilotycin Gluceptate is a drug marketed by Dista and is included in one NDA.
The generic ingredient in ILOTYCIN GLUCEPTATE is erythromycin gluceptate. There are one hundred and three drug master file entries for this compound. Additional details are available on the erythromycin gluceptate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ILOTYCIN GLUCEPTATE?
- What are the global sales for ILOTYCIN GLUCEPTATE?
- What is Average Wholesale Price for ILOTYCIN GLUCEPTATE?
Summary for ILOTYCIN GLUCEPTATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 9 |
| Patent Applications: | 593 |
| DailyMed Link: | ILOTYCIN GLUCEPTATE at DailyMed |
US Patents and Regulatory Information for ILOTYCIN GLUCEPTATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dista | ILOTYCIN GLUCEPTATE | erythromycin gluceptate | INJECTABLE;INJECTION | 050370-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dista | ILOTYCIN GLUCEPTATE | erythromycin gluceptate | INJECTABLE;INJECTION | 050370-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dista | ILOTYCIN GLUCEPTATE | erythromycin gluceptate | INJECTABLE;INJECTION | 050370-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
